PortfoliosLab logoPortfoliosLab logo
DCTH vs. NUTX
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

DCTH vs. NUTX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Delcath Systems, Inc. (DCTH) and Nutex Health Inc (NUTX). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, DCTH achieves a 2.28% return, which is significantly higher than NUTX's -19.31% return.


DCTH

1D
-1.90%
1M
-6.26%
YTD
2.28%
6M
6.94%
1Y
-35.76%
3Y*
12.32%
5Y*
-0.81%
10Y*

NUTX

1D
6.24%
1M
-9.74%
YTD
-19.31%
6M
0.82%
1Y
-10.33%
3Y*
25.11%
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

DCTH vs. NUTX - Yearly Performance Comparison


2026 (YTD)2025202420232022
DCTH
Delcath Systems, Inc.
2.28%-16.11%189.42%15.56%-45.04%
NUTX
Nutex Health Inc
-19.31%419.47%17.37%-90.53%-95.25%

Correlation

The correlation between DCTH and NUTX is 0.05, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.05

Correlation (3Y)
Calculated over the trailing 3-year period

0.13

Correlation (All Time)
Calculated using the full available price history since Apr 5, 2022

0.11

Fundamentals

EPS

DCTH:

$0.01

NUTX:

$19.08

PE Ratio

DCTH:

703.34

NUTX:

6.96

PS Ratio

DCTH:

6.03

NUTX:

0.76

Total Revenue (TTM)

DCTH:

$65.45M

NUTX:

$879.95M

Gross Profit (TTM)

DCTH:

$77.75M

NUTX:

$417.67M

EBITDA (TTM)

DCTH:

$222.00K

NUTX:

$275.94M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

DCTH vs. NUTX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

DCTH
DCTH Risk / Return Rank: 1515
Overall Rank
DCTH Sharpe Ratio Rank: 1010
Sharpe Ratio Rank
DCTH Sortino Ratio Rank: 1313
Sortino Ratio Rank
DCTH Omega Ratio Rank: 1414
Omega Ratio Rank
DCTH Calmar Ratio Rank: 1515
Calmar Ratio Rank
DCTH Martin Ratio Rank: 2121
Martin Ratio Rank

NUTX
NUTX Risk / Return Rank: 3838
Overall Rank
NUTX Sharpe Ratio Rank: 3636
Sharpe Ratio Rank
NUTX Sortino Ratio Rank: 4242
Sortino Ratio Rank
NUTX Omega Ratio Rank: 4141
Omega Ratio Rank
NUTX Calmar Ratio Rank: 3535
Calmar Ratio Rank
NUTX Martin Ratio Rank: 3535
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

DCTH vs. NUTX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Delcath Systems, Inc. (DCTH) and Nutex Health Inc (NUTX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


DCTHNUTXDifference
Sharpe ratioReturn per unit of total volatility

-0.62

Sortino ratioReturn per unit of downside risk

-1.43

Omega ratioGain probability vs. loss probability

0.89

1.06

-0.17

Calmar ratioReturn relative to maximum drawdown

-0.70

-0.19

-0.51

Martin ratioReturn relative to average drawdown

-0.95

-0.34

-0.61

DCTH vs. NUTX - Sharpe Ratio Comparison

The current DCTH Sharpe Ratio is -0.73, which is lower than the NUTX Sharpe Ratio of -0.11. The chart below compares the historical Sharpe Ratios of DCTH and NUTX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


DCTHNUTXDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.73

-0.11

-0.62

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.01

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.44

-0.45

+0.01

Drawdowns

DCTH vs. NUTX - Drawdown Comparison

The maximum DCTH drawdown since its inception was -99.96%, roughly equal to the maximum NUTX drawdown of -99.93%. Use the drawdown chart below to compare losses from any high point for DCTH and NUTX.


Loading charts...

Drawdown Indicators


DCTHNUTXDifference

Max Drawdown

Largest peak-to-trough decline

-99.96%

-99.93%

-0.03%

Max Drawdown (1Y)

Largest decline over 1 year

-51.45%

-54.32%

+2.87%

Max Drawdown (3Y)

Largest decline over 3 years

-68.97%

-94.36%

+25.39%

Max Drawdown (5Y)

Largest decline over 5 years

-82.21%

Current Drawdown

Current decline from peak

-99.83%

-97.79%

-2.04%

Average Drawdown

Average peak-to-trough decline

-96.46%

-97.27%

+0.81%

Ulcer Index

Depth and duration of drawdowns from previous peaks

37.62%

32.67%

+4.95%

Volatility

DCTH vs. NUTX - Volatility Comparison

The current volatility for Delcath Systems, Inc. (DCTH) is 11.04%, while Nutex Health Inc (NUTX) has a volatility of 26.07%. This indicates that DCTH experiences smaller price fluctuations and is considered to be less risky than NUTX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


DCTHNUTXDifference

Volatility (1M)

Calculated over the trailing 1-month period

11.04%

26.07%

-15.03%

Volatility (6M)

Calculated over the trailing 6-month period

31.71%

67.36%

-35.65%

Volatility (1Y)

Calculated over the trailing 1-year period

48.91%

95.95%

-47.04%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

73.07%

133.33%

-60.26%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

110.13%

133.33%

-23.20%

Dividends

DCTH vs. NUTX - Dividend Comparison

Neither DCTH nor NUTX has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

DCTH vs. NUTX - Financials Comparison

This section allows you to compare key financial metrics between Delcath Systems, Inc. and Nutex Health Inc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0050.00M100.00M150.00M200.00M250.00M202220232024202520260
216.49M
(DCTH) Total Revenue
(NUTX) Total Revenue
Values in USD except per share items

Frequently Asked Questions


DCTH and NUTX have a correlation of 0.05, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

NUTX has higher volatility (26.07%) compared to DCTH (11.04%). In terms of maximum drawdown, DCTH dropped -99.96% vs NUTX's -99.93%.

NUTX currently has the higher Sharpe Ratio (-0.11 vs -0.73), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for DCTH and NUTX

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer